3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Nivolumab
17
Ipilimumab
14
pembrolizumab
11
Cyclophosphamide
8
trametinib
7
dabrafenib
6
Interleukin-2
6
aldesleukin
5
Vemurafenib
5
Radiotherapy
5
sargramostim
4
130-nm albumin-bound paclitaxel
4
fludarabine
3
encorafenib
3
binimetinib
3
Specimen Handling
3
Radiosurgery
3
Melphalan
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
fludarabine phosphate
2
Magnetic Resonance Spectroscopy
2
Introns
2
Infliximab
2
Celecoxib
2
CTLA-4 Antigen
2
Biopsy
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
yeast-CEA vaccine
1
vitespin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Melanoma
×
Patient-Specific Modeling
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn